Daratumumab for the treatment of multiple myeloma.
Scott R. Goldsmith, N. Foley, Mark A. Schroeder
págs. 591-605
Evinacumab to treat hypercholesterolemia.
Clemens Engler, Christoph Ebenbichler
págs. 607-619
Selpercatinib for lung and thyroid cancers with RET gene mutations or fusions.
H. Zheng, Zhe-Sheng Chen, Jing Li
págs. 621-629
Drug Information Association (DIA) 2021 Global Annual Meeting (June 26-July 1, 2021 – Virtual Meeting).
R. Kaur
págs. 631-637
European Society of Cardiology (ESC) Congress 2021 (August 27-30, 2021 – Virtual Meeting).
Gary Croasdell
págs. 639-643
New product intros [aducanumab-avwa, aviptadil, belumosudil mesylate, belzutifan (first-in-class), disitamab vedotin, dostarlimab-gxly, fuzuloparib, hetrombopag olamine, ibrexafungerp, imeglimin hydrochloride (first-in-class), infigratinib, Kconvac].
págs. 645-648
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: